Pitman MR - Search Results

1

Dipeptidyl peptidase 8 and 9--guilty by association?

Pitman MR, Sulda ML, Kuss B, Abbott CA. Pitman MR, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14(10):3619-33. doi: 10.2741/3476. Front Biosci (Landmark Ed). 2009. PMID: 19273298 Free article. Review.

2

Prediction of dipeptidyl peptidase (DP) 8 structure by homology modelling.

Pitman MR, Menz RI, Abbott CA. Pitman MR, et al. Adv Exp Med Biol. 2006;575:33-42. doi: 10.1007/0-387-32824-6_4. Adv Exp Med Biol. 2006. PMID: 16700506 No abstract available.

3

Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8.

Ajami K, Pitman MR, Wilson CH, Park J, Menz RI, Starr AE, Cox JH, Abbott CA, Overall CM, Gorrell MD. Ajami K, et al. Among authors: pitman mr. FEBS Lett. 2008 Mar 5;582(5):819-25. doi: 10.1016/j.febslet.2008.02.005. Epub 2008 Feb 12. FEBS Lett. 2008. PMID: 18275857 Free article.

4

The in vivo expression of dipeptidyl peptidases 8 and 9.

Yu DM, Ajami K, Gall MG, Park J, Lee CS, Evans KA, McLaughlin EA, Pitman MR, Abbott CA, McCaughan GW, Gorrell MD. Yu DM, et al. Among authors: pitman mr. J Histochem Cytochem. 2009 Nov;57(11):1025-40. doi: 10.1369/jhc.2009.953760. Epub 2009 Jul 6. J Histochem Cytochem. 2009. PMID: 19581630 Free PMC article.

5

Hydrophilic residues surrounding the S1 and S2 pockets contribute to dimerisation and catalysis in human dipeptidyl peptidase 8 (DP8).

Pitman MR, Menz RI, Abbott CA. Pitman MR, et al. Biol Chem. 2010 Aug;391(8):959-72. doi: 10.1515/BC.2010.111. Biol Chem. 2010. PMID: 20536396

6

Identifying natural substrates for dipeptidyl peptidases 8 and 9 using terminal amine isotopic labeling of substrates (TAILS) reveals in vivo roles in cellular homeostasis and energy metabolism.

Wilson CH, Indarto D, Doucet A, Pogson LD, Pitman MR, McNicholas K, Menz RI, Overall CM, Abbott CA. Wilson CH, et al. Among authors: pitman mr. J Biol Chem. 2013 May 17;288(20):13936-13949. doi: 10.1074/jbc.M112.445841. Epub 2013 Mar 21. J Biol Chem. 2013. PMID: 23519473 Free PMC article.

7

The sphingosine 1-phosphate receptor 2/4 antagonist JTE-013 elicits off-target effects on sphingolipid metabolism.

Pitman MR, Lewis AC, Davies LT, Moretti PAB, Anderson D, Creek DJ, Powell JA, Pitson SM. Pitman MR, et al. Sci Rep. 2022 Jan 10;12(1):454. doi: 10.1038/s41598-021-04009-w. Sci Rep. 2022. PMID: 35013382 Free PMC article.

8

Inhibitors of the sphingosine kinase pathway as potential therapeutics.

Pitman MR, Pitson SM. Pitman MR, et al. Curr Cancer Drug Targets. 2010 Jun;10(4):354-67. doi: 10.2174/156800910791208599. Curr Cancer Drug Targets. 2010. PMID: 20370685 Review.

9

Recent advances in the development of sphingosine kinase inhibitors.

Pitman MR, Costabile M, Pitson SM. Pitman MR, et al. Cell Signal. 2016 Sep;28(9):1349-1363. doi: 10.1016/j.cellsig.2016.06.007. Epub 2016 Jun 11. Cell Signal. 2016. PMID: 27297359 Review.

10

Topical Application of Fingolimod Perturbs Cutaneous Inflammation.

Sun WY, Dimasi DP, Pitman MR, Zhuang Y, Heddle R, Pitson SM, Grimbaldeston MA, Bonder CS. Sun WY, et al. Among authors: pitman mr. J Immunol. 2016 May 1;196(9):3854-64. doi: 10.4049/jimmunol.1501510. Epub 2016 Mar 21. J Immunol. 2016. PMID: 27001955

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page